|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Available-for-sale, at fair value (amortized cost of $3,892,806 and allowance for credit losses of $522 at 9/30/26) (amortized cost of $3,642,362 and allowance for credit losses of $828 at 12/31/25) | ||||||||||||||||||||
| Equity securities, at fair value (cost - $523,206 at 9/30/26 and $534,311 at 12/31/25) | ||||||||||||||||||||
| Short-term investments, at cost which approximates fair value | ||||||||||||||||||||
| Other invested assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Total investments and cash | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Premiums and reinsurance balances receivable, net of allowances for uncollectible amounts of $21,629 at 9/30/26 and $23,673 at 12/31/25 | ||||||||||||||||||||
| Ceded unearned premium | ||||||||||||||||||||
| Reinsurance balances recoverable on unpaid losses and settlement expenses, net of allowances for uncollectible amounts of $10,643 at 9/30/26 and $11,107 at 12/31/25 | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Property and equipment, at cost, net of accumulated depreciation of $90,456 at 9/30/26 and $84,459 at 12/31/25 | ||||||||||||||||||||
| Investment in unconsolidated investees | ||||||||||||||||||||
| Goodwill and intangibles | ||||||||||||||||||||
| Income taxes-deferred | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Unpaid losses and settlement expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Reinsurance balances payable | ||||||||||||||||||||
| Funds held | ||||||||||||||||||||
| Income taxes-current | ||||||||||||||||||||
| Income taxes-deferred | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock ($0.01 par value) (Shares authorized - 400,000,000) (137,931,006 shares issued, 91,732,032 shares outstanding at 9/30/26) (137,739,079 shares issued, 91,878,651 shares outstanding at 12/31/25) | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive earnings (loss) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Deferred compensation | ||||||||||||||||||||
| Less: Treasury shares, at cost (46,198,974 shares at 9/30/26 and 45,860,428 shares at 12/31/25) | ||||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
